Hoivik, Hodneland and colleagues employ convoluted neural networks alongside radiogenomic biomarkers to profile endometrial tumors. They identify an 11-gene high-risk signature validated with retrospective patient data.
- Erling A. Hoivik
- Erlend Hodneland
- Camilla Krakstad